U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
BEFOVACIMAB
INN  
Official Name English
BAY-1093884
Preferred Name English
HUMAN TISSUE FACTOR PATHWAY INHIBITOR-NEUTRALIZING ANTIBODY (BAY 1093884)
Common Name English
IMMUNOGLOBULIN G2, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL 1093884 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 1093884 .LAMBDA.-CHAIN, DIMER
Common Name English
BAY1093884
Code English
befovacimab [INN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 678219
Created by admin on Sat Dec 16 14:16:55 GMT 2023 , Edited by admin on Sat Dec 16 14:16:55 GMT 2023
FDA ORPHAN DRUG 685719
Created by admin on Sat Dec 16 14:16:55 GMT 2023 , Edited by admin on Sat Dec 16 14:16:55 GMT 2023
Code System Code Type Description
CAS
2156634-62-5
Created by admin on Sat Dec 16 14:16:55 GMT 2023 , Edited by admin on Sat Dec 16 14:16:55 GMT 2023
PRIMARY
INN
11125
Created by admin on Sat Dec 16 14:16:55 GMT 2023 , Edited by admin on Sat Dec 16 14:16:55 GMT 2023
PRIMARY
FDA UNII
8FFQ0L4R3B
Created by admin on Sat Dec 16 14:16:55 GMT 2023 , Edited by admin on Sat Dec 16 14:16:55 GMT 2023
PRIMARY
NCI_THESAURUS
C171827
Created by admin on Sat Dec 16 14:16:55 GMT 2023 , Edited by admin on Sat Dec 16 14:16:55 GMT 2023
PRIMARY
ACTIVE MOIETY
BEFOVACIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966